The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.

The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.

It is not clear whether elevated levels of the fibrinolytic inhibitor, plasminogen activator inhibitor-1 (PAl-1) in Type 2 diabetes mellitus are the result of obesity or coexistent atherosclerosis. Therefore the relationship between PAl-1 and insulin resistance, determined by the homeostasis model a...

Descripció completa

Dades bibliogràfiques
Autors principals:	Gough, S, Rice, P, McCormack, L, Chapman, C, Grant, P
Format:	Journal article
Idioma:	English
Publicat:	1993

Ítems similars

The fibrinolytic response to exercise at diagnosis and after 12 months in patients with type 2 diabetes mellitus
per: Gough, S, et al.
Publicat: (1994)

Insulin edema in an adolescent girl with newly diagnosed Type 1 diabetes mellitus
per: Rekha Krishnan, et al.
Publicat: (2022-01-01)

Study of phases of insulin secretion in pre-diabetes and newly diagnosed type 2 diabetes mellitus
per: Sabreena Mohtarin, et al.
Publicat: (2016-07-01)

Selective activation of blood T cells in children with newly diagnosed insulin dependent diabetes mellitus.
per: Kontiainen, S, et al.
Publicat: (1994)

Diabetic lipemia in a newly diagnosed diabetes mellitus
per: Doua K. Al Homyani, et al.
Publicat: (2021-12-01)

Serum magnesium status and its correlation with insulin resistance in newly diagnosed patients with type 2 diabetes mellitus
per: Mohammed Ruhul-Kabir, et al.
Publicat: (2019-04-01)

Irisin, a new envoy in newly diagnosed type 2 diabetes mellitus – A plausible association with insulin resistance
per: Saffalya Nayak, et al.
Publicat: (2022-06-01)

Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
per: Gaber El-Saber Batiha, et al.
Publicat: (2022-09-01)

Diabetic ketoacidosis precipitated by COVID-19 in patient with newly diagnosed diabetes mellitus
per: E. Xhardo, et al.
Publicat: (2021-09-01)

Safety and effectiveness of the sodium‐glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus
per: Michael J. Hadd, et al.
Publicat: (2023-05-01)

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
per: Le TD, et al.
Publicat: (2020-06-01)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
per: Nurbadriah binti Jasmiad, et al.
Publicat: (2022-09-01)

Relationship between the early initiation of insulin treatment and diabetic complications in patients newly diagnosed with type 2 diabetes mellitus in Korea: A nationwide cohort study
per: Ha‐Lim Jeon, et al.
Publicat: (2022-05-01)

The fibrinolytic system in diabetes mellitus.
per: Gough, S, et al.
Publicat: (1991)

Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus. A cross-sectional study.
per: Gough, S, et al.
Publicat: (1995)

Cerebellin and Catecholamines in Newly Diagnosed Hypertension With and Without Diabetes Mellitus
per: Sedat Çiçek, et al.
Publicat: (2023-01-01)

Nerve conduction abnormalities in patients with newly diagnosed diabetes mellitus
per: Aditya Prakash Kulkarni, et al.
Publicat: (2018-01-01)

Neurophysiological evaluation in newly diagnosed Diabetes Mellitus type 1
per: Matanovic Dragana, et al.
Publicat: (2013-08-01)

Insulin Resistance and β-Cell Function of Lean versus Overweight or Obese Filipino Patients with Newly Diagnosed Type 2 Diabetes Mellitus
per: Francesca Paula Bautista, et al.
Publicat: (2019-11-01)

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
per: Mu X, et al.
Publicat: (2023-07-01)

PREVALENCE OF DIABETIC RETINOPATHY IN PATIENTS WITH NEWLY DIAGNOSED TYPE II DIABETES MELLITUS
per: A. Abdollahi, et al.
Publicat: (2006-12-01)

PREVALENCE OF DIABETIC RETINOPATHY IN PATIENTS WITH NEWLY DIAGNOSED TYPE II DIABETES MELLITUS
per: A. Bostak, et al.
Publicat: (2006-11-01)

Insulin Resistance is the Predominant Pathophysiologic Feature of Hyperglycemia in Newly Diagnosed Overweight and Obese Type 2 Diabetes Mellitus in two University Hospitals in Malaysia
per: Foo Siew-Hui, et al.
Publicat: (2014-05-01)

An investigation of the associations among sleep duration and quality, body mass index and insulin resistance in newly diagnosed type 2 diabetes mellitus patients
per: Teresa Arora, et al.
Publicat: (2016-02-01)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
per: Dretzke, J, et al.
Publicat: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
per: Dretzke, J, et al.
Publicat: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
per: Dretzke, J, et al.
Publicat: (2004)

Cytokines Profile in Newly Diagnosed Children with Type 1 Diabetes Mellitus
per: Eman M. Saleh
Publicat: (2009-10-01)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
per: J Dretzke, et al.
Publicat: (2004-06-01)

Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
per: Heng Wan, et al.
Publicat: (2016-01-01)

Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes
per: Xiaohan Tang, et al.
Publicat: (2022-11-01)

Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea
per: Jang Won Son, et al.
Publicat: (2015-10-01)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
per: Chang-Yuan Liu, et al.
Publicat: (2019-08-01)

The effect of short-term exercise on plasma procoagulant activity in patients with type II (non-insulin-dependent) diabetes and healthy volunteers.
per: Ibbotson, S, et al.
Publicat: (1993)

Newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign
per: Hoon Park, et al.
Publicat: (2014-02-01)

Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
per: Gruzdeva O, et al.
Publicat: (2013-08-01)

Increased serum extrachromosomal circular DNA SORBS1circle level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus
per: Xiang Kong, et al.
Publicat: (2024-01-01)

Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
per: Xingxing Ren, et al.
Publicat: (2016-01-01)

Level of Organochlorine Pesticide in Prediabetic and Newly Diagnosed Diabetes Mellitus Patients with Varying Degree of Glucose Intolerance and Insulin Resistance among North Indian Population
per: Shipra Tyagi, et al.
Publicat: (2021-07-01)

Pharmacogenetic aspects of vildagliptin treatment in patients with newly diagnosed type 2 diabetes mellitus
per: P. B. Shorokhova, et al.
Publicat: (2019-10-01)